Pay in 4 interest-free payments of $5.58 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Drugs Today 47 , 99107 (2011)
Liraglutide, dulaglutide, or other options might suit patients with unique conditions
For patients with significant obesity or related conditions, that risk-benefit calculation tends to come out clearly in favor of treatment
[PMID: 2420277] PubMed record related to this compound for laboratory literature review
Results showed that liraglutide provided glycemic control comparable to or better than these alternatives, with additional benefits such as reduced weight gain and fewer hypoglycemic episodes (36)
US$ 25.59
US$ 21.52
US$ 26.07
US$ 20.67
